Andres H. Gutiérrez

ORCID: 0000-0002-6127-8327
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • vaccines and immunoinformatics approaches
  • Monoclonal and Polyclonal Antibodies Research
  • Influenza Virus Research Studies
  • Immunotherapy and Immune Responses
  • Animal Disease Management and Epidemiology
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Microbial infections and disease research
  • Mycobacterium research and diagnosis
  • Research on Leishmaniasis Studies
  • T-cell and B-cell Immunology
  • Congenital Anomalies and Fetal Surgery
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Parasitic infections in humans and animals
  • Hepatitis C virus research
  • Viral Infections and Immunology Research
  • Respiratory viral infections research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Biochemical and Molecular Research
  • Parasitic Infections and Diagnostics
  • Virus-based gene therapy research
  • Bacterial Infections and Vaccines
  • Malaria Research and Control

Providence College
2014-2024

EpiVax (United States)
2015-2024

University of Rhode Island
2012-2017

Institute for Medical Informatics and Biostatistics
2012-2015

Universidad Peruana Cayetano Heredia
2009-2013

Farvet (Peru)
2013

Response Technologies (United States)
2002

Computational vaccine design, also known as computational vaccinology, encompasses epitope mapping, antigen selection and immunogen design using tools. The iVAX toolkit is an integrated set of tools that has been in development since 1998 by De Groot Martin. It comprises a suite immunoinformatics algorithms for triaging candidate antigens, selecting immunogenic conserved T cell epitopes, eliminating regulatory optimizing antigens immunogenicity protection against disease. applied to programs...

10.1080/21645515.2015.1061159 article EN Human Vaccines & Immunotherapeutics 2015-07-09

Advances in the field of T cell immunology have contributed to understanding that cross-reactivity is an intrinsic characteristic receptor (TCR), and each TCR can potentially interact with many different epitopes. To better define potential for between epitopes derived from human genome, microbiome, pathogens, we developed a new immunoinformatics tool, JanusMatrix, represents extension validated epitope mapping EpiMatrix. Initial explorations, summarized this synopsis, uncovered what appear...

10.4161/hv.24615 article EN Human Vaccines & Immunotherapeutics 2013-04-12

In silico immunogenicity risk assessment has been an important step in the development path for many biologic therapeutics, including monoclonal antibodies. Even if source of a given is 'fully human', T cell epitopes that are contained sequences may activate immune system, enabling anti-drug antibodies can reduce drug efficacy and contribute to adverse events. Computational tools identify from primary amino acid have used assess immunogenic potential therapeutic candidates several decades....

10.1080/19420862.2024.2333729 article EN cc-by-nc mAbs 2024-03-27

Hypothesis While conventional in silico immunogenicity risk assessments focus on measuring based the potential of therapeutic proteins to be processed and presented by a global population-wide set human leukocyte antigen (HLA) alleles T cells, future refinements might adjust for HLA allele frequencies different geographic regions or populations, as well individuals those populations. Adjustment distribution may reveal patterns that are specific population groups individuals, which current...

10.3389/fimmu.2024.1377911 article EN cc-by Frontiers in Immunology 2024-05-15

ABSTRACT Despite high quality standards and continual process improvements in manufacturing, host cell protein (HCP) impurities remain a substantial risk for biological products. Even at low levels, residual HCPs can induce detrimental immune response compromising the safety efficacy of biologic. Consequently, advanced‐stage clinical trials have been cancelled due to identification antibodies against HCPs. To enable earlier rapid assessment risks Chinese Hamster Ovary (CHO)‐based production...

10.1002/bit.25286 article EN cc-by-nc-nd Biotechnology and Bioengineering 2014-06-02

Abstract Natural and vaccine-induced SARS-CoV-2 immunity in humans has been described but correlates of protection are not yet defined. T cells support the antibody response, clear virus-infected cells, may be required to block transmission. In this study, we identified peptide epitopes associated with T-cell immunity. Using immunoinformatic methods, from spike, membrane, envelope were selected for maximal HLA-binding potential, coverage HLA diversity, circulating virus, minimal potential...

10.1038/s41541-021-00331-6 article EN cc-by npj Vaccines 2021-05-13

Avian-origin H7N9 influenza is a novel A virus (IAV) that emerged in humans China 2013. Using immunoinformatics tools, we identified several T cell epitopes with receptor (TCR)-facing residues identical to those of multiple from human proteins. We hypothesized host tolerance these peptides may impair helper response and contribute the low titer, weak hemagglutination inhibiting (HI) antibody responses diminished seroconversion rates have been observed infections vaccine trials. found...

10.1080/21645515.2015.1052197 article EN Human Vaccines & Immunotherapeutics 2015-06-19

High strain sequence variability, interference with innate immune mechanisms, and epitope deletion are all examples of strategies that pathogens have evolved to subvert host defenses. To this list we would add another strategy: camouflage. Pathogens whose sequences cross-conserved multiple human proteins at the TCR-facing residues may be exploiting "ignorance tolerance," which mechanisms by mature T cells avoid responses self-antigens. By adopting amino acid configurations recognized...

10.4161/hv.36134 article EN Human Vaccines & Immunotherapeutics 2014-11-01

Swine influenza is a highly contagious respiratory viral infection in pigs that responsible for significant financial losses to pig farmers annually. Current measures protect herds from include: inactivated whole-virus vaccines, subunit and alpha replicon-based vaccines. As true vaccines humans, these strategies do not provide broad protection against the diverse strains of A virus (IAV) currently circulating U.S. swine. Improved approaches developing swine are needed. Here, we used...

10.1371/journal.pone.0159237 article EN public-domain PLoS ONE 2016-07-13

SUMMARY Introduction . Evaluation of Leishmania drug susceptibility depends on in vitro Sb V assays, which are labour-intensive and may give a biased view the true parasite resistance. Molecular markers urgently needed to improve simplify monitoring -resistance. We analysed here gene expression profile 21 L. braziliensis clinical isolates defined as -resistant -sensitive, order identify potential resistance markers. Methods The differential 13 genes involved metabolism, oxidative stress or...

10.1017/s0031182010001095 article EN Parasitology 2010-08-03

Immune recognition of foreign proteins by T cells hinges on the formation a ternary complex sandwiching constituent peptide protein between major histocompatibility (MHC) molecule and cell receptor (TCR). Viruses have evolved means "camouflaging" themselves, avoiding immune reducing MHC and/or TCR binding their peptides. Computer-driven epitope mapping tools been used to evaluate degree which particular viruses this response, but most such analyses focus MHC-facing 'agretopes'. Here we set...

10.1186/1471-2105-15-s4-s1 article EN cc-by BMC Bioinformatics 2014-03-01

Over many years, recombinant protein biologics developers have addressed product immunogenicity with a focus on the active pharmaceutical ingredient. Recently, immune responses to native host cell proteins (HCP) gained attention, as they too may an effect response formulated drug, namely diminished drug safety and efficacy. The recent suspension of two clinical trials due presence antibodies Chinese Hamster Ovary (CHO) HCPs in subjects treated biologic clearly reveals serious concern...

10.4161/hv.22378 article EN Human Vaccines & Immunotherapeutics 2012-09-16

Visceral leishmaniasis (VL) is a serious parasitic disease for which control measures are limited and drug resistance increasing. First second generation vaccine candidates have not been successful. The goal of the present study was to select possibly immunogenic L. donovani GP63 peptides using immunoinformatics tools test their immunogenicity in vitro. amino acid sequence [GenBank accession: ACT31401] screened EpiMatrix algorithm putative T cell epitopes that would bind most common HLA...

10.4161/hv.21881 article EN Human Vaccines & Immunotherapeutics 2012-10-23

Porcine circovirus type 2 (PCV2) has one of the highest evolutionary rates among DNA viruses. Traditionally, PCV2 vaccines have been based on 2a genotype as this was first discovered. Today, eight genotypes viruses identified, and, taken together with rapid rate, propensity to recombine, and high rate vaccination, further variation in is expected. For these reasons, there a growing genetic gap between available field strains. When selecting vaccines, it important consider that contain T cell...

10.1016/j.vetimm.2020.110034 article EN cc-by-nc-nd Veterinary Immunology and Immunopathology 2020-03-06

T cell epitope prediction tools and associated vaccine design algorithms have accelerated the development of vaccines for humans. Predictive swine other food animals are not as well developed, primarily because data required to develop lacking. Here, we overcome a lack construct predictors by systematically leveraging available human information. Applying "pocket profile method", use sequence structural similarities in binding pockets major histocompatibility complex proteins infer Swine...

10.1186/s12859-015-0724-8 article EN cc-by BMC Bioinformatics 2015-09-14

The RTS,S/AS01 malaria vaccine will undergo a pilot vaccination study in sub-Saharan Africa beginning 2019. Phase III trials reported an efficacy of 28.3% (children 5-17 months) and 18.3% (infants 6-12 weeks), with substantial variability across sites. We postulated that the relatively low RTS,S sites may be due to lack T-cell epitopes antigen, HLA distribution vaccinated population, and/or 'immune camouflage', immune escape mechanism. To examine these hypotheses, we used immunoinformatics...

10.1080/21645515.2018.1560772 article EN cc-by-nc-nd Human Vaccines & Immunotherapeutics 2019-01-08

The in silico prediction of T cell epitopes within any peptide or biologic drug candidate serves as an important first step for assessing immunogenicity. bind human leukocyte antigen (HLA) by a well-characterized interaction amino acid side chains and pockets the HLA molecule binding groove. Immunoinformatics tools, such EpiMatrix algorithm, have been developed to screen natural sequences peptides that will HLA. In addition commonly occurring synthetic impurities, unnatural acids (UAA) are...

10.3389/fddsv.2022.952326 article EN cc-by Frontiers in Drug Discovery 2022-10-10

Zika virus (ZIKV) is a flavivirus primarily transmitted by Aedes species mosquitoes, first discovered in Africa 1947, that disseminated through Southeast Asia and the Pacific Islands 2000s. The ZIKV infections Americas were identified 2014, exploded populations Brazil other countries 2015/16. infection during pregnancy can cause severe brain eye defects offspring, adults has been associated with higher risks of Guillain-Barré syndrome. We initiated study to describe natural history (the...

10.3389/fimmu.2023.1247876 article EN cc-by Frontiers in Immunology 2023-08-29

Pyrazinamidase of Mycobacterium tuberculosis catalyzes the conversion pyrazinamide to active molecule pyrazinoic acid. Reduction pyrazinamidase activity results in a level resistance. Previous studies have suggested that has metal-binding site and divalent metal cofactor is required for activity. To determine effect metals on pyrazinamidase, recombinant wild-type corresponding H37Rv pyrazinamide-susceptible reference strain was expressed Escherichia coli with without carboxy terminal....

10.4269/ajtmh.2012.10-0565 article EN American Journal of Tropical Medicine and Hygiene 2012-07-02
Coming Soon ...